Zydus Cadila to sell one animal health business for Rs 2,921 crore ANI | Updated: May 12, 2021 12:27 IST
Ahmedabad (Gujarat) [India], May 12 (ANI): Pharmaceutical major Zydus Cadila said on Wednesday it has signed agreements to sell one of its animal health business companies to Multiples Alternate Asset Management led consortium for Rs 2,921 crore.
The consortium includes Canada Pension Plan Investment Board and RARE Enterprises. The slump sale transaction is expected to be complete within 90 days.
Zydus Animal Health and Investments Ltd (ZAHL) has leadership position across a wide spectrum of therapeutic and nutritional products for livestock and poultry animal segments. It employs 700 people and has one manufacturing facility in Haridwar.
Cadila Healthcare’s (Zydus Cadila’s) wholly-owned material subsidiary Zydus Animal Health and Investments (ZAHL) is set to sell its animal healthcare business to a consortium led by Multiples Alternate Asset Management for nearly Rs 3,000 crore.
Zydus Cadila on Wednesday announced ZAHL has entered into a business transfer agreement and other ancillary pacts to sell and transfer its animal healthcare unit to the Multiples-led consortium. The deal is to sell one of the two business undertakings of ZAHL on a slump-sale basis as a going concern, for Rs 2,921 crore on a cash free and debt free basis, subject to certain closing date adjustments and other conditions.
Zydus Cadila to sell its India focused animal health biz for Rs 2,921 cr to Multiples, RARE
By IANS |
Published on
Wed, May 12 2021 12:48 IST |
3 Views
Rupee. (File Photo: IANS). Image Source: IANS News
New Delhi, May 12 : Zydus Animal Health and Investments Limited (ZAHL) a wholly owned material subsidiary of Cadila Healthcare Limited, has entered into a Business Transfer Agreement (BTA) and other ancillary agreements to sell and transfer its Animal Healthcare Established Markets Undertaking to Multiples Alternate Asset Management led consortium.
Zydus AH is the animal health business of ZAHL focused on India and certain other countries. The consortium, including Canada Pension Plan Investment Board and RARE Enterprises has agreed to purchase the undertaking through an SPV controlled by them, in the name of Zenex Animal Health India Private Limited.
Zydus Cadila entity to sell its India focused Animal Health Business to Multiples Alternate Asset Management led consortium equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
Zydus to sell animal healthcare business to Zenex for ₹2,921 crore
May 12, 2021
×
Inks agreement to sell businesses in India and some other countries by way of a slump sale
Cadila Healthcare Limited (Zydus Cadila) on Wednesday said its wholly-owned Zydus Animal Health and Investment Limited (ZAHL) has entered into a Business Transfer Agreement with Zenex Animal Health India Private Limited to sell itsanimal healthcare business.
Zydus will sell the Animal Healthcare Established Markets Undertaking - the animal healthcare business in India and certain other countries - by way of a slump sale- for an estimated consideration amount of ₹2,921 crore, subject to certain closing date adjustments in terms of the Definitive Agreements, the company said in a regulatory filing.